Key facts: Sanofi will invest over $20 billion in the U.S. by 2030 to boost manufacturing and research, focusing on capacity expansion and partnerships. Tariffs are expected to have minimal impact in 2025.
Moins d'1 minute de lecture
- Sanofi will invest over $20 billion in the U.S. by 2030 to boost manufacturing and research, focusing on capacity expansion and partnerships. Tariffs are expected to have minimal impact in 2025.1
- Sanofi announced a new initiative to provide a month's supply of any of its insulin products for $35 to all U.S. patients with a valid prescription, regardless of their insurance status.2
- Sanofi is under investigation by the European Commission for potential antitrust violations, following unannounced inspections at its facilities in France and Germany.3